How new metabolites affect valvular heart disease
Official title: Mechanism and Effect of Novel Metabolites on Valvular Heart Disease(Hestia Study)
Run by Sun Yat-sen University · NCT07065500 · Data updated 2026-11-12
This project will test whether newly identified metabolites influence disease progression and outcomes in adults with valvular heart disease.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 4000 (estimated) |
| Sponsor | Sun Yat-sen University Academic / other |
| Locations | 1 site (Guangzhou, Guangdong) |
| Status | Recruiting |
| Started | August 1, 2025 |
| Main results expected | March 1, 2030 |
| Study ends | March 1, 2030 |
| Registry record updated | September 2, 2025 |
| Trial ID | NCT07065500 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older with a clinical diagnosis of any form of valvular heart disease who can give informed consent are ideal candidates.
✕Probably not a fit
People without valvular heart disease, those unable to provide informed consent, or those looking for an immediate therapeutic intervention are unlikely to benefit directly.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational, long-term follow-up study of adults with clinically diagnosed valvular heart disease conducted at the First Affiliated Hospital of Sun Yat-sen University. Investigators will collect clinical data and biological specimens, then perform metabolite testing on tissue samples to identify novel metabolic markers. The study aims to link metabolic signatures to risk factors, mechanisms of valve damage, and patient prognosis. Results will be used to generate hypotheses for future diagnostic biomarkers or targeted interventions.
Why it matters
Potential benefit: If successful, the study could identify metabolic markers that help predict who will worsen and point to new targets for earlier or more personalized treatment.
How similar studies have gone: Metabolomics has shown promise in other areas of cardiovascular disease, but applying detailed metabolite-mechanism studies specifically to valvular heart disease remains relatively novel and not yet well established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥18 years, gender is not limited. 2. Clinical diagnosis of heart valve disease (including aortic stenosis, aortic valve closure insufficiency due to different etiologies, mitral stenosis, mitral valve closure insufficiency, pulmonic stenosis, pulmonic valve closure insufficiency, tricuspid stenosis and tricuspid closure insufficiency due to different etiologies ) Exclusion Criteria: Patients unable to provide informed consent
Where it's running
-
The First Affiliated Hospital of Sun Yat-sen Univerity
Guangzhou, Guangdong, China Recruiting
Study contacts
- Study coordinator: Xiaodong Zhuang
- Email: zhuangxd3@mail.sysu.edu.cn
- Phone: +8613760755035
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Hydra THV Transfemoral Valve Implantation in Severe Aortic Stenosis
This registry tests how safely and effectively the Hydra THV works when implanted through the femoral artery in adults with severe symptomatic aortic stenosis.
-
Heart sound signals to detect valve and artery disease early
This observational study tests whether a new digital stethoscope-like device can pick up heart sound patterns to detect valvular or coronary artery disease earlier in people who are already getting heart imaging.
-
Pulmonary Vascular Disease in Valvular Heart Disease: How Valve Procedures Affect Blood Flow
This study tests how blood flow in the lungs changes in adults with left-sided valve disease who are having valve surgery and looks to see if patterns can predict reversibility of tricuspid regurgitation and right heart dysfunction.
-
DELINEATE-Prospective: AI-assisted echocardiogram analysis for valve disease
This project will test whether an AI system can automatically analyze echocardiograms to help doctors detect valve problems in adults who get heart ultrasounds.
-
MMVD: A Multicenter Registry to Understand Multiple and Mixed Valvular Heart Disease
This study tests how common MMVD is, what imaging and management practices are used, and what factors influence outcomes in adults with two or more valve issues.
-
Aortic valve sizing: comparing CT scan measurements with measurements taken during surgery for people having surgical aortic valve replacement
This will see if CT scan measurements match the aortic valve sizes surgeons measure during surgical aortic valve replacement in adults with severe aortic stenosis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.